Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 16, 2025
Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
GlobeNewswire
·
April 16, 2025
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023
GlobeNewswire
·
April 16, 2025
AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, pancreatic ductal …
Sonnet Releases Virtual Investor "What This Means" Segment
GlobeNewswire
·
April 16, 2025
- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means" video here PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) …
Biomerica Announces Reverse Stock Split
GlobeNewswire
·
April 16, 2025
IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse stock split of the issued and outstanding shares of …
NeuroOne® Issues Letter to Shareholders
GlobeNewswire
·
April 16, 2025
Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a …
Doheny Eye Institute Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
GlobeNewswire
·
April 16, 2025
PASADENA, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research at the upcoming …
Sienna Senior Living Completes Previously Announced Acquisition in Ottawa
GlobeNewswire
·
April 16, 2025
MARKHAM, Ontario, April 16, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a 165-suite retirement residence in Ottawa, Ontario (" …
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
GlobeNewswire
·
April 16, 2025
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a series of events to commemorate National Infertility Awareness Week (NIAW) and Canadian Fertility …
Epilepsy Foundation of America Launches Comprehensive Epilepsy & Seizure Safe Classrooms Toolkit for K-12 Educators
GlobeNewswire
·
April 16, 2025
BOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud to announce the release of the Epilepsy …
Better Choice Sells Halo’s Business in Asia for $8.1 Million in Total Gross Proceeds Including $6.5 Million in Cash Up Front, the Equivalent of $3.34 Per Share
GlobeNewswire
·
April 16, 2025
TAMPA, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that its wholly-owned subsidiary, Halo, Purely for Pets, Inc. (“ …
Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
GlobeNewswire
·
April 16, 2025
Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
GlobeNewswire
·
April 16, 2025
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
GlobeNewswire
·
April 16, 2025
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …
TRIMEDX named a Top 100 finalist in the 2025 North America Inspiring Workplaces Awards
GlobeNewswire
·
April 16, 2025
Indianapolis, Indiana, April 16, 2025 (GLOBE NEWSWIRE) -- TRIMEDX―a leading independent clinical asset management company delivering clinical engineering services, clinical asset informatics, and medical device cybersecurity―has once again been named a …
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
GlobeNewswire
·
April 16, 2025
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company’s LIBERATE-1 clinical trial from which topline …
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
GlobeNewswire
·
April 16, 2025
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this quarter or in the third quarter LITTLETON, …
Conduit Pharmaceuticals Announces Leadership Changes
GlobeNewswire
·
April 16, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced key leadership changes to support the company’s next phase …
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
GlobeNewswire
·
April 16, 2025
New patent underscores breadth of application and expansion opportunities for Company’s catheter-based technology Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications THE WOODLANDS, TX, April …
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
GlobeNewswire
·
April 16, 2025
FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced the appointment of …
Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
GlobeNewswire
·
April 16, 2025
WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Addgene, an organization empowering discovery by providing scientists with a vast catalog of expertly curated and quality-controlled plasmids, viral vectors, and recombinant antibodies, today announced …